116 related articles for article (PubMed ID: 24751349)
1. Comparative uptake of ¹⁸F-FEN-DPAZn2, ¹⁸F-FECH, ¹⁸F-fluoride, and ¹⁸F-FDG in fibrosarcoma and aseptic inflammation.
Liang X; Tang G; Wang H; Hu K; Tang X; Nie D; Sun T; Huang T
Appl Radiat Isot; 2014 Aug; 90():158-64. PubMed ID: 24751349
[TBL] [Abstract][Full Text] [Related]
2. Semi-automatic synthesis and biodistribution of N-(2-
Wen F; Nie D; Hu K; Tang G; Yao S; Tang C
BMC Med Imaging; 2017 Apr; 17(1):27. PubMed ID: 28431519
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex.
Wang H; Tang X; Tang G; Huang T; Liang X; Hu K; Deng H; Yi C; Shi X; Wu K
Apoptosis; 2013 Aug; 18(8):1017-27. PubMed ID: 23613106
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
[TBL] [Abstract][Full Text] [Related]
5. A comparative uptake study of multiplexed PET tracers in mice with turpentine-induced inflammation.
Huang T; Wang H; Tang G; Liang X; Nie D; Yi C; Wu K
Molecules; 2012 Nov; 17(12):13948-59. PubMed ID: 23183886
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
Tang G; Wang M; Tang X; Luo L; Gan M
Nucl Med Biol; 2003 Oct; 30(7):733-9. PubMed ID: 14499331
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Liu RS; Chou TK; Chang CH; Wu CY; Chang CW; Chang TJ; Wang SJ; Lin WJ; Wang HE
Nucl Med Biol; 2009 Apr; 36(3):305-12. PubMed ID: 19324276
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
Sugae S; Suzuki A; Takahashi N; Minamimoto R; Cheng C; Theeraladanon C; Endo I; Togo S; Inoue T; Shimada H
Ann Nucl Med; 2008 Jan; 22(1):65-72. PubMed ID: 18250989
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.
van Waarde A; Jager PL; Ishiwata K; Dierckx RA; Elsinga PH
J Nucl Med; 2006 Jan; 47(1):150-4. PubMed ID: 16391199
[TBL] [Abstract][Full Text] [Related]
10. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.
Hara T; Kosaka N; Kishi H
J Nucl Med; 2002 Feb; 43(2):187-99. PubMed ID: 11850483
[TBL] [Abstract][Full Text] [Related]
11. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Lahoutte T; Mertens J; Caveliers V; Franken PR; Everaert H; Bossuyt A
J Nucl Med; 2003 Sep; 44(9):1489-94. PubMed ID: 12960197
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts.
Kristian A; Riss P; Qu H; Milde M; Schoultz BW; Engebraaten O; Mælandsmo GM; Malinen E
Acta Oncol; 2014 Aug; 53(8):1086-92. PubMed ID: 25017377
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Pellegrino D; Bonab AA; Dragotakes SC; Pitman JT; Mariani G; Carter EA
J Nucl Med; 2005 Sep; 46(9):1522-30. PubMed ID: 16157536
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
17. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation.
Kubota K; Furumoto S; Iwata R; Fukuda H; Kawamura K; Ishiwata K
Ann Nucl Med; 2006 Oct; 20(8):527-33. PubMed ID: 17134019
[TBL] [Abstract][Full Text] [Related]
19. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.
Yamada S; Kubota K; Kubota R; Ido T; Tamahashi N
J Nucl Med; 1995 Jul; 36(7):1301-6. PubMed ID: 7790960
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
